Holen Sie sich die Stockscreener-App
4.04
1.70%
-0.07
Handel nachbörslich:
4.05
0.010
+0.25%
Schlusskurs vom Vortag:
$4.11
Offen:
$4.17
24-Stunden-Volumen:
104.92K
Relative Volume:
0.36
Marktkapitalisierung:
$35.15M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-30.98M
KGV:
-0.3308
EPS:
-12.2116
Netto-Cashflow:
$-31.84M
1W Leistung:
-6.37%
1M Leistung:
+13.17%
6M Leistung:
-1.46%
1J Leistung:
-68.51%
1-Tages-Spanne:
$4.01
$4.33
1-Wochen-Bereich:
$3.97
$4.40
52-Wochen-Spanne:
$2.60
$14.68
Briacell Therapeutics Corp Stock (BCTX) Company Profile
Firmenname
Briacell Therapeutics Corp
Sektor
Branche
Telefon
(604) 921-1810
Adresse
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Compare BCTX vs VRTX, MRNA, REGN, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BCTX
Briacell Therapeutics Corp
|
4.04 | 37.54M | 0 | -30.98M | -31.84M | -12.21 |
VRTX
Vertex Pharmaceuticals Inc
|
504.73 | 127.93B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
190.01 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
735.20 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.21 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.64 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-02-14 | Eingeleitet | H.C. Wainwright | Buy |
Briacell Therapeutics Corp Aktie (BCTX) Neueste Nachrichten
BrightView Goes Pink for Third Annual Breast Cancer Awareness Campaign - Yahoo! Finance Canada
BriaCell Therapeutics Corp. (TSX:BCT) Gains 5.17% as Phase 3 Progress and Expanding Cancer Pipeline Support Sentiment - kalkine.ca
BriaCell Therapeutics Corp Warrant 2026-15.01.31 On BriaCell Therap Financial Disclosures & SEC Filings - TradingView
BCTX Forecast — Price Target — Prediction for 2027 - TradingView
BriaCell Therapeutics Corp. (TSX:BCT): Immunotherapy Pipeline Progress and Clinical Momentum Drive Renewed Investor Confidence - kalkine.ca
Stocks in play: Medicenna Therapeutics Corp. - Yahoo! Finance Canada
BriaCell Therapeutics Warrant (BCTXL) Retreats 11.3% as Traders Test Support Near $0.97Factor Rotation - siam.in
Q&A: Advancing cancer biotech therapies with a multipronged approach - digitaljournal.com
Why Did BriaCell Therapeutics (TSX:BCT) Surge 18.876% on 17 September 2026? - kalkine.ca
BriaCell (BCTXZ) Rallies +1.01% as Bulls Target $0.16 2026-09-17ETF Premium Discount - siam.in
BriaCell (BCTX) Jumps +5.06% — Is Institutional Money Flowing In? 2026-09-17Butterfly Setup - dars.gov.et
BriaCell phase 3 breast cancer study gets seventh DSMB approval By Investing.com - Investing.com Nigeria
BriaCell (BCTX) Phase 3 Trial Safety Endorsement Highlights Mark - GuruFocus
Data Safety Monitoring Board Recommends Continuing BriaCell's Phase 3 Metastatic Breast Cancer Study - Investing News Network
BriaCell phase 3 breast cancer study gets seventh DSMB approval - Investing.com
Data Safety Monitoring Board (DSMB) Recommends Continuing BriaCell’s Phase 3 Metastatic Breast Cancer Study - GlobeNewswire
A breast cancer trial gets a seventh recommendation to continue - Stock Titan
Price to sales forward of BriaCell Therapeutics Corp. – NASDAQ:BCTXL - TradingView
Price to earnings forward of BriaCell Therapeutics Corp. – NASDAQ:BCTXL - TradingView
Enterprise value to revenue forward of BriaCell Therapeutics Corp. – NASDAQ:BCTXL - TradingView
(BCT) Market Dynamics and Trading Signals (BCT:CA) - Stock Traders Daily
Price to book forward of BriaCell Therapeutics Corp. – NASDAQ:BCTXL - TradingView
Neonc Technologies Holdings, Briacell Therapeutics and Oncolytics Biotech Have Report Clinical and Regulatory Developments Across Brain, Breast and Colorectal Cancer - marketscreener.com
Equity in earnings of BriaCell Therapeutics Corp – HAM:8BT - TradingView
Book value per share of BriaCell Therapeutics Corp – HAM:8BT - TradingView
BriaCell Therapeutics Corp. (TSX:BCT) Advances as Immunotherapy Pipeline Progress and Clinical Momentum Drive Investor Optimism - kalkine.ca
Net income before discontinued operations of BriaCell Therapeutics Corp – HAM:8BT - TradingView
Free float of BriaCell Therapeutics Corp – HAM:8BT - TradingView
Nature Medicine features a BriaCell trial among 11 shaping medicine in 2026 - Stock Titan
(BCT) Strategic Equity Report (BCT:CA) - Stock Traders Daily
BriaCell Therapeutics Corp (BCTXW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
BriaCell Therapeutics Corp (BCTXW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Briacell Therapeutics Corp (BCTX) Key Financial Ratios – Valuation, Profitability & More - Value Research
Enterprise value to revenue forward of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
Briacell Therapeutics Corp (BCTX) Peer Comparison – Compare with Others - Value Research
Briacell Therapeutics Corp (BCTX) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Certain Warrants of BriaCell Therapeutics Corp. are subject to a Lock-Up Agreement Ending on 2-SEP-2026. - marketscreener.com
Certain Options of BriaCell Therapeutics Corp. are subject to a Lock-Up Agreement Ending on 2-SEP-2026. - marketscreener.com
BriaCell's Cell-Based ‘Melanoma’ Enters the Skin Cancer Vaccine Conversation - Investing News Network
BriaCell Therapeutics Stock Faces Renewed Pressure as Biotech Volatility Tests Investor Conviction - kalkine.ca
BriaCell Therapeutics Corp. (TSX:BCT) Falls 4.24% as Clinical-Stage Risk and Volatility Pressure Sentiment - kalkine.ca
BriaCell Therapeutics Corp (BCTXW) Key Financial Ratios – Valuation, Profitability & More - Value Research
BriaCell Therapeutics Corp (BCTXW) Peer Comparison – Compare with Others - Value Research
Briacell Therapeutics Corp (BCTX) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
BriaCell Therapeutics Stock Falls Sharply: Can TSX:BCT Stabilize After Renewed Biotech Selling Pressure? - kalkine.ca
BriaCell Therapeutics Warrant (BCTXL) Climbs 2.79% to $0.96 as Biotech Warrants Draw Fresh AttentionBreakaway Gap - dars.gov.et
BriaCell Therapeutics Stock Falls 6.41%: Why TSX:BCT Is in Focus as Breast and Prostate Cancer Pipeline Advances - kalkine.ca
BriaCell Therapeutics Corp. (TSX:BCT) Gains Momentum as Immunotherapy Pipeline Progress Supports Investor Optimism - kalkine.ca
BriaCell Therapeutics (TSX:BCT) Advances 6.6% on a Run of Pipeline Milestones - kalkine.ca
BriaCell in Focus: TSX: BCT Investors Watch Major Immunotherapy Milestones Ahead of Clinical Data - kalkine.ca
BriaCell Therapeutics Stock Slides 13.31%: Can Clinical Execution Overcome Renewed Biotech Pressure? - kalkine.ca
Finanzdaten der Briacell Therapeutics Corp-Aktie (BCTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):